Blood Filtration For Bowel Disease Safe, Not Decisively Effective – UK Panel
This article was originally published in The Gray Sheet
Executive SummaryClinical efficacy data currently fail to support leukapheresis as a treatment for inflammatory bowel disease, the UK's Interventional Procedures Advisory Committee (IPAC) asserts in a Jan. 27 consultation document
You may also be interested in...
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.